Dr. Margaret MacMillan, MD
Claim this profileUniversity of Minnesota Masonic Cancer Center
Studies Bone Marrow Failure Syndrome
Studies Anemia
5 reported clinical trials
12 drugs studied
Area of expertise
1Bone Marrow Failure Syndrome
Stage IV
SAMD9 positive
SAMD9L positive
2Anemia
FANCA positive
SAMD9 positive
SAMD9L positive
Affiliated Hospitals
Clinical Trials Margaret MacMillan, MD is currently running
TCD HCT
for Fanconi Anemia
This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) peripheral blood stem cell (PBSC) transplantation in patients with inherited bone marrow failure (BMF) disorders to eliminate the need for routine graft-versus-host disease (GVHD) immune suppression leading to earlier immune recovery and potentially a reduction in the risk of severe infections after transplantation.
Recruiting3 awards Phase 28 criteria
Stem Cell Transplantation
for Blood Cancers
This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (α/β TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies
Recruiting1 award Phase 2
More about Margaret MacMillan, MD
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Margaret MacMillan, MD has experience with
- Fludarabine
- Busulfan
- Levetiracetam
- Melphalan
- Rituximab
- T Cell Receptor Α/β TCD HCT
Breakdown of trials Margaret MacMillan, MD has run
Bone Marrow Failure Syndrome
Anemia
Pancytopenia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret MacMillan, MD specialize in?
Margaret MacMillan, MD focuses on Bone Marrow Failure Syndrome and Anemia. In particular, much of their work with Bone Marrow Failure Syndrome has involved Stage IV patients, or patients who are SAMD9 positive.
Is Margaret MacMillan, MD currently recruiting for clinical trials?
Yes, Margaret MacMillan, MD is currently recruiting for 2 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Margaret MacMillan, MD has studied deeply?
Yes, Margaret MacMillan, MD has studied treatments such as Fludarabine, Busulfan, Levetiracetam.
What is the best way to schedule an appointment with Margaret MacMillan, MD?
Apply for one of the trials that Margaret MacMillan, MD is conducting.
What is the office address of Margaret MacMillan, MD?
The office of Margaret MacMillan, MD is located at: University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.